8-K - Neumora Therapeutics, Inc. Common Stock | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 5, 2026, Neumora Therapeutics, Inc. (the “Company”) issued press releases announcing positive results from its Phase 1b signal-seeking

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release (NMRA-511 Phase 1b Study) dated January 5, 2026 99.2 Press release (P

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2